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On the basis of experimental studies the authors have demonstrated that a topical issue of the phar- 
maceutical science today is development of the rational therapeutic dosage forms based on standar- 
dized biologically active substances of bee products that have specific chemical and pharmacological 
properties for new domestic, natural, highly effective drugs for prevention and treatment of ulcer diseases  
of the human gastroduodenal area. The pharmaceutical market of drugs with the antiulcer activity of 
different dosage forms has been analyzed. It has been found that dosage forms produced in a small 
range are economically and socially efficient for further development of a completely new drug based 
on bee products. Today science has proven that encapsulated dosage forms are promising. This dosage 
form is a cost effective, and allows to encapsulate various drugs from substances in the solid state 
to liquid and pasty ingredients. Research in recent years has confirmed that the choice of a rational 
dosage form of drugs in combination with excipients provide the optimal pharmacological effect of 
drugs under development, which production is possible both in industrial and pharmacy conditions.
The study of natural medicinal resources of our coun-
try in order to seek new sources of biologically active 
substances and creation of national drugs on their basis 
is a topical issue of pharmacy.
Continuing the experiments with the results pre-
sented in the publication [2] the aim of this study was to 
develop an optimal composition and the rational tech-
nology of a solid dosage form – capsules for treating ul-
cerative gastroduodenal diseases.
As for this problem, bee products (pollen, propolis, 
honey, bee venom, royal jelly, bee bread) are of particu-
lar interest as sources of the raw material. Volumes of 
their procurement in Ukraine (the data of 1995) are: pro- 
polis – 20 tons, pollen – 100 tons, bee venom – 200 kg, 
honey – 40,000-60,000 tons, royal jelly – 100 kg and 
wax – 800 tons. This amount is sufficient for industrial 
production of drugs, besides it is a domestic raw mate-
rial that is always at hand, and its transport costs are 
negligible.
Since ancient times bee products are widely used in 
folk medicine to treat various diseases [19]. Fundamental 
research of domestic and foreign scientists has proven 
their high biological value and versatile pharmacologi-
cal activity (anti-inflammatory, antimicrobial, anesthetic, 
antioxidant, immune-stimulating, antiradiation, antiulcer, 
hepatoprotective, etc.). Moreover, they are practically 
harmless to the human body [2, 3, 4, 8, 10, 15, 18].
Today specialized companies of Romania, Germa-
ny, France, Spain, Canada, Japan, Czech Republic and 
others produce a rich variety of bee products. In addi-
tion, analysis of the literary data has shown that a lot 
of publications are devoted to the research concerning 
the use of apidrugs in medical practice: in dermatology, 
surgery, gynecology, otolaryngology, dentistry and es-
pecially gastroenterology [3]. For example, in the treat-
ment of stomach ulcers disappearance of heartburn, 
pain, improvement of appetite and the patients’ general 
state are observed from the first days of administration 
of a combination of propolis with rosehip oil and vita-
min E [3, 8, 10].
In treatment of chronic gastritis with low acidity 
of the gastric juice a good result is achieved when us-
ing honey and kalanchoe emulsions with propolis and 
aloe juice. This treatment promotes regeneration of the 
mucous membrane of the stomach, improves the blood 
circulation and stimulates the gastric secretion. In cases 
when intake of honey causes heartburn, propolis and oil 
solution with vitamin E is used.
The advantage of apidrugs is the fact that they (unlike, 
for example, antibiotics) do not damage the normal intes-
tinal microflora, and only inhibit pathogens (this treatment 
does not lead to dysbiosis) [8]. Moreover, if antibiotics 
inhibit the body’s defenses, on the contrary, drugs with 
propolis stimulate them. They also have other pharma-
cological properties that are very useful in the treatment 
of peptic ulcer and other gastrointestinal diseases [8, 19].
Propolis drugs are multi-component systems of bio- 
logically active substances. They contain more than 50 sub- 
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stances of different chemical poisons. The main groups 
are resins, balms, essential oils and wax, as well as mine- 
rals, vitamins, amino acids (from 8 to 17) and others. It 
has been found that flavonoids are more than 25% of all 
components of propolis.
Investigations of such researchers as S.A.Popravko, 
O.I.Tikhonov, V.I.Litvinenko and others have shown that 
flavones (luteolin, apigenin, etc.), flavonols (quercetin, 
kaempferol, etc.), flavanones, phenolic acids (caffeic, 
coumaric, ferulic, etc.) are in the composition of propo-
lis. The presence of terpenoids, such as acetoxybetule-
nol, bisabolol, aromatic aldehyde, isovanillin, benzoic 
acid has been also found. In this regard, academician 
Tikhonov O.I. developed waste-free processing of the raw 
propolis, and it allowed to offer the Ukrainian health-
care a number of purified biologically active standar- 
dized substances of propolis and apidrugs created on 
their basis [4, 5, 6, 7, 8].
Taking into consideration the abovementioned, we 
have studied almost all types of dosage forms, which 
are the most optimal for development of drugs, have a 
high therapeutic efficacy, bioavailability, and are cur-
rently being developed in a small range. As can be seen 
from Fig. 1, the most interesting is the dosage form in 
the form of capsules.
Capsules are a very common dosage form in develo- 
ped countries. For example, in the USP XXIII there are 
more than 220 articles on capsules, in the BP 1993 they are 
over 50. This dosage form allows to encapsulate various 
drugs: hard capsules filled with substances in the solid state 
(powders, granules, microcapsules, etc.), soft capsules 
filled with liquid and pasty ingredients. Pure substances, 
without any additives (e.g. antibiotics) are often used as 
the content of capsules. In the pharmaceutical industry a 
direct filling of capsules with medicinal substances is quite 
common. But some of them do not meet the technological 
requirements of industrial equipment by their physical and 
chemical characteristics and can not be filled to the cap-
sular shell without using the special methods to eliminate 
their technological disadvantages. For example, granula-
tion, introduction of excipients, etc., are widely used.
Capsules are a dosage form; they are often intend-
ed for internal use, more rarely for vaginal, rectal, and 
other routes of administration. There are two types of 
capsules: soft gelatin capsules (Capsules molles) and 
solid ones with caps (Capsules dure averculatae).
Recognition of a capsule dosage form and the grow-
ing interest to it is explained by a high bioavailability 
and a number of advantages. They have a good appear-
ance, can eliminate a bitter taste, an unpleasant appear-
ance or odour of medicinal substances, and many pecu-
liarities such as:
Stability. In the manufacture of capsules medicinal 
substances are not exposed to heat, encapsulation of drugs 
can be intact (without wet granulation, pressure). Sealed 
capsule keeps medicinal substances from microbial con-
tamination, exposure to air, light, moisture, dust, me-
chanical external actions, fluctuations in temperature. 
Furthermore, the capsule shell provides protection of 
the mucous membranes from the irritant action of cer-
tain medicines, and the latter, in turn, from the destruc-
tive effect on digestive enzymes.
A high bioavailability. Gelatin capsules are readily 
soluble, permeating for digestive juices, and the phar-
macological action of the medicinal substance reveals 
rather quickly (in an average of 4-8 min).
Rather high bioavailability of encapsulated dosage 
forms is explained by the fact that the composition of 
the shell includes gelatin – the product of partial hydro-
lysis of the collagen-containing raw material. Collagen 
is the main protein component of fibrous connective tis-
sues of mammals. In the basis of its protein molecule 
there is a polypeptide chain formed by twelve amino 
acids, most of which are essential to the human body. 
The main acids are glycine (27%), proline (16%), oxy-
proline (14%), lysine (5%) and others. Gelatin is easily 
and rapidly absorbed even in severe disorders of the gas-
trointestinal tract; moreover, it is indifferent and non-
toxic.
Ease of use. Gelatin capsules are odourless and taste-
less, and thanks to their shape and surface properties 
they are easy to use. As mentioned above, the basic ma-
Fig. 1. The share of capsules at the pharmaceutical market compared to other dosage forms for internal administration.
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terial of the shell is gelatin, which is a natural protein 
that is easily digestible by the body. In oral administra-
tion the gelatin shell is wetted with saliva in the mouth, 
glides well, thus, a capsule slips easily even with a slight 
gulp. The shell quickly swells and dissolves in the gastro-
intestinal tract. Capsules can be transparent or opaque, 
painted in different colours (to prevent photochemical 
reactions of photosensitive substances, giving capsules 
a good marketable appearance).
When encapsulating the undesirable effects of mois-
ture (as in wet granulation) or pressure (as in pressing 
tablets) for some labile substances can be avoided. The 
content of capsules may be solid or pasty (for gelatin 
capsules with caps) and consists of one or more medici-
nal substances with a possible introduction of various 
excipients approved for medical use.
Focus of the therapeutic action. The ability to pro-
vide a medicinal product specific properties is achieved 
by introduction of excipients to the walls of the capsule, 
their tanning or coating with special films. Due to it, to 
obtain capsules with different release rates and locali-
zation of drug action is possible.
Physiological inertness. Modern production of cap-
sules is fully mechanized. With the automated method 
of filling a high accuracy of dosing (with standard de-
viation of ± 3%) and the minimal loss of drugs are gua- 
ranteed.
The advantages of gelatin capsules listed provide 
them a wide distribution in medicine. The disadvantag-
es of capsules include their hygroscopicity, which pre-
vents encapsulation of aqueous solutions, and the need 
to satisfy certain conditions of storage.
Medicinal substances used to fill gelatin capsules 
should be dosed at temperatures not exceeding 35°C in 
order to prevent softening and destruction of capsules. 
In addition, they should not dissolve the capsule shell, 
do not have any negative impact, do not evolve gaseous 
substances, do not increase in volume in order not to 
cause tearing of capsules, as well as not to cause tan-
ning of capsules from the inside and reduction of their 
solubility in the gastrointestinal tract.
In industry, to fill gelatin capsules the automated 
complete production lines equipped with elements of 
robotics, electronics and microprocessor technology 
with efficiency of several hundred thousand capsules 
per shift are used. In addition to the main technological 
processes in manufacturing capsules there are auxiliary 
processes associated with regeneration of wastes, sort-
ing and packing capsules, etc. On the automated lines 
capsules closed with caps are delivered automatically 
from the storage drum, substandard and nonstandard 
capsules are rejected, other capsules are oriented in a 
position comfortable for filling, caps are opened, cap-
sules are filled with a powdered or granulated medicinal 
substance, then they are closed, substandard and empty 
capsules are rejected and collected in special containers. 
The filled capsules are delivered for dispensing and pack-
ing. Dosing on such automatic lines is carried out by 
volume using piston-type, vacuum, screw or vibration 
dosing devices (accuracy of dose ± 2%).
Hard capsules (see their classification in Table) have 
the shape of a cylinder with hemispherical ends and 
consist of two parts: a shell and a cap; both parts must 
be free to enter one another without forming gaps. The 
inner diameter of the cap should match the outer diam-
eter of the shell. They have special grooves and projec-
tions for the “lock” that prevents opening the capsule 
during transportation. When connecting two parts they 
form a standard-size container. Capsules should have a 
smooth surface with no visible damage and mechanical 
or air inclusions. For coloration of capsules such dyes 
as tartrazine, indigo, titanium dioxide, and their various 
mixtures, which are permitted for medical application, 
are used.
Gelatin is a favourable medium for the growth and 
reproduction of microorganisms; in its composition there 
are stabilizing and preserving agents such as sodium 
metabisulphate, benzoic acid, sodium benzoate, etc. To 
prevent dissolution of capsules in the stomach aceto- 
phthalate cellulose (4%) is also introduced to the compo-
sition of the capsule mass. Sometimes flavouring agents 
are added into the capsule mass to give a pleasant odour, 
and sugar as a sugar syrup is added to improve the fla-
vour of the capsule when swallowing. In some cases, 
medicinal substances that have the local anesthetic ac-
tion (benzocaine) are introduced to the composition of 
the gelatinous mass to form a capsule shell [15, 16, 17].
Humidity and temperature are the factors that af-
fect the gelatin capsule quality. For their best storage 
it is desirable to keep temperature within 15-20°C and 
humidity should be 30-40%.
Wide possibilities of prescribing drugs in the form 
of capsules caused an increase in their production and 
use around the world. After starting the use of antibio- 
tics that have an unpleasant bitter taste in medical prac- 
tice there was a growing interest of manufacturers to 
encapsulated dosage forms. Over the past decades (from 
the 1950-s) there has been production of modern auto-
matic machines for manufacturing gelatin capsules in 
industrial-scale volumes, and it has become possible to 
manufacture encapsulated drugs of different pharmaco-
logical groups (anticonvulsants, antiarrhythmic agents, 
hypnotics, sedatives, anthelmintic agents, laxatives, di-
uretics, hypocholesterolemic agents, tranquilizers and 
drugs with the antiulcer action) [7, 9].
The growth rate of manufacturing drugs in capsules 
is far ahead of other similar indicators concerning solid 
dosage forms (Fig. 2).
Table
Classification of hard capsules by size
Number 000 00 0 1 2 3 4 5
Average capsule size, cm3 1.37 0.95 0.68 0.5 0.37 0.3 0.21 0.13
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But along with this, the nomenclature of encapsu-
lated drugs is small in our country and it is at the stage 
of development.
Taking into account the abovementioned, we con-
clude that Ukraine has all the necessary conditions (raw 
material, research and development, scientific person-
nel, etc.) for manufacture of domestic solid (capsules) 
dosage forms from bee products (both in the conditions 
of a chemist’s shop and pharmaceutical factories) and 
for further development of one of the areas of medicine – 
apitherapy.
In terms of the above, to solve this problem we have 
conducted the research on selection and use not only of 
biologically active substances, but excipients as well.
The term “excipients” summarizes a large group 
of substances, both of natural and synthetic and semi-
synthetic origin. Their use in pharmaceutical technolo- 
gy is always based on the following prerequisites: be 
indifferent towards the macroorganism; to active ingre-
dients; have forming properties.
In terms of the classical drug technology the lat-
ter feature was dominant when choosing and assessing 
excipients for drug manufacture since a dosage form as 
the final result is estimated as the form that is the most 
suitable for application, transportation and storage [17].
With the introduction of the biopharmaceutical con-
cept (G.Levy, J.Wagner) in the pharmaceutical technolo- 
gy in the early 60-s the assessment of excipients as those 
that provide the creation of a dosage form was changed. 
At present excipients are considered to be potential carriers 
of definite biological effects revealed in their combina-
tion with medicinal substances. They are an independent 
integral part of drugs, a component that forms chemical 
bonds with the active medicinal substance – inclusion 
compounds. Therefore, introduction of a certain type of 
excipients in a particular dosage form requires special 
studies (biopharmaceutical ones) in terms of their inter-
action with drugs.
In this respect, science-based application of excipi-
ents is one of the objectives of biopharmaceutics – cre-
ation of a dosage form with an optimal composition, 
rational technology and high biological availability [1].
If medicinal substances provide the therapeutic effect 
of drugs, then excipients serve a dual function: firstly, 
they help to form the easily dosed mass, and secondly, 
they provide release of a medicinal substance from the 
dosage form [11].
The content of excipients should be minimized, or 
more specifically, it should be optimal, so that their in-
fluence reduces to facilitating technology and providing 
physiological availability. In this regard, the number of 
some excipients is regulated by certain limits. Thus, the 
total number of excipients should not exceed 20% of 
the mass of medicinal substances (excluding diluents, 
their number is not subjected to limitation). The amount 
of talc should not exceed 3%, stearic acid, calcium stea-
rate or magnesium, Tween-80 should be 1% of the total 
mass.
All excipients must be chemically indifferent, do 
not have a negative effect on the quality of mixtures 
in their preparation, transportation and storage, should 
maximize the assimilation of active ingredients by the 
body. Depending on their purpose they are divided into 
the following groups: diluents, disintegrating agents lu-
bricants, adhesives, adsorbents, corrigents.
The group of diluents include substances that are 
used to produce the required weight of capsules when 
a medicinal substance is in their composition in small 
doses (0.01-0.001 g). The main substances used for this 
purpose are beet and milk sugar, glucose, sodium chlo-
ride, urea, calcium sulphate, basic magnesium carbon-
ate, calcium hydrogen phosphate, etc. Mannitol, sorbi-
Fig. 2. Production of capsules in the world for the whole period.
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tol, bentonite, sodium bicarbonate, dextrose, starch can 
be used as a diluent. Recently the arsenal of fillers has 
been replenished with such substances as cellulose de-
rivatives, modified starches and others. Numerous stud-
ies have demonstrated the possibility of using cellulose 
derivatives, including microcrystalline cellulose, etc., 
as fillers [8, 14].
The USP also recommends such diluents as calcium 
carbonate, dibasic calcium phosphate, tribasic calcium 
phosphate, calcium sulphate, microcrystalline cellulose, 
powdered cellulose, dextrates, dextrin, dextrose, fructose, 
kaolin, lactose, mannitol, sorbitol, starch, gelatinous starch, 
sucrose, pressed sugar, confectioner’s sugar.
The role of diluents in the manufacture of capsules 
is rather significant: they largely determine stability of 
a drug, the extent and rate of its disgestion.
Lubricants are substances that improve the flowa-
bility of the powder mixture when filling of capsules, 
as well as reduce adhesion of the mass to machine parts, 
collectors, etc. Improved flowability of the material is 
needed for fast, accurate and uniform filling of capsules. 
As a result of good lubricity of the mass, the continu-
ous operation of the encapsulation system and uniform 
dispensing of drugs sre achieved.
Substances that enhance lubricity include calcium 
stearate, glycerol behenate, clarified mineral oil, poly-
ethylene glycol, stearine sodium fumarate, purified stearic 
acid, talc, hydrogenated vegetable oil, zinc stearate, starch, 
fat-free milk powder, aerosil, calcium silicate, magne-
sium silicate, colloidal silica. Recently the use of talc is 
limited because it is not indifferent [19].
To reduce sticking of the material to machine parts 
the substances, which are often called antiadherent sub-
stances or adhesives such as stearic acid, its calcium 
and magnesium salts, hydrocarbons (ceresin, liquid and 
solid paraffin) silicon carbon, are used.
By the mechanism of the lubricity action lubricants 
are divided into three groups:
• substances that improve the flowability of granules 
(starch, talc, polyethylene glycol, aerosil);
• antiadhesive substances (stearic acid, paraffin, sili- 
cone lubricants);
• substance of the mixed type (calcium, magnesium, 
and aluminum stearate).
Adsorbents are substances added to the powder mix-
ture in cases where it is composed of oils, fats and hy-
groscopic components. Absorbing the excessive mois-
ture adsorbents provide flowability of the mass, that is 
why they are also called hydrostats. Bentonites, kaolin, 
aerosil, magnesium oxide and basic carbonate, aluminum 
oxide hydrate are also used as adsorbents.
There is no sense to use corrigents in the manufac-
ture of capsules because the gelatin shell masks the taste 
and odour of medicinal substances; in addition, they do 
not require introduction of a binder if the manufactur-
ing process does not include the stage of preliminary 
granulation [7, 14].
Analyzing the abovementioned, the next stage of 
our research will be to identify physical, chemical and 
technological properties and characteristics of standard-
ized biologically active substances of bee products, ex-
cipients and their mixtures for creating an encapsulated 
dosage form, i.e. fluidity, the angle of repose, bulk weight, 
bulk density, moisture content and moisture absorption, 
selection of the number of capsules by the known me- 
thods.
CONCLUSIONS
1. It has been shown that a topical issue of the phar- 
maceutical science today is development of the rational 
therapeutic dosage forms for prevention and treatment 
of ulcer diseases of the human gastroduodenal area.
2. The pharmaceutical market of drugs with the anti- 
ulcer activity of different dosage forms has been ana-
lyzed.
3. Research in recent years has confirmed that the 
choice of a rational dosage form of medicinal substances 
in combination with excipients provide the optimal phar- 
macological effect of drugs under development. Today 
encapsulated dosage forms are promising; their production 
is possible both in industrial and pharmacy conditions. 
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МЕТОДОЛОГІЯ СТВОРЕННЯ КАПСУЛЬОВАНИХ ЛІКАРСЬКИХ ФОРМ З ПРОДУКТАМИ 
БДЖІЛЬНИЦТВА. Повідомлення II
Н.С.Богдан, О.І.Тихонов
Ключові слова: продукти бджільництва; гранули; капсули; противиразкова дія
На основі експериментальних досліджень авторами показано, що актуальною темою фар-
мацевтичної  науки сьогодення є розробка раціональних терапевтичних лікарських форм 
на основі біологічно активних стандартизованих субстанцій продуктів бджільництва, які 
мають специфічні хімічні і фармакологічні властивості для створення нових вітчизняних, 
природних, високоефективних лікарських засобів для профілактики та лікування виразко-
вих захворювань гастродуоденальної зони людини. Проаналізовано фармацевтичний ринок 
лікарських препаратів противиразкової активності різних лікарських форм і з’ясовано, що 
лікарські форми, які виробляються в незначному асортименті, є економічно і соціально до-
цільними для подальшої розробки нового лікарського препарату на основі продуктів бджіль-
ництва. На теперішній час наукою доведено, що перспективними у даних дослідженнях є 
капсульовані лікарські форми. Досліджувана лікарська форма економічно вигідна та дозволяє 
капсулювати різноманітні лікарські засоби: від речовин, які знаходяться в твердому стані, до 
рідких і пастоподібних інгредієнтів. Науковими дослідженнями останніх років підтверджено, 
що вибір раціональної лікарської форми лікарських речовин у комплексі з допоміжними сполу-
ками забезпечує оптимальну фармакологічну дію розроблюваних препаратів, виготовлення 
яких можливе як у промислових, так і в аптечних умовах.
МЕТОДОЛОГИЯ СОЗДАНИЯ КАПСУЛИРОВАННЫХ ЛЕКАРСТВЕННЫХ ФОРМ  
С ПРОДУКТАМИ ПЧЕЛОВОДСТВА. Сообщение II
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На основе экспериментальных исследований авторами показано, что актуальной темой 
фармацевтической науки сегодня является разработка рациональных терапевтических ле-
карственных форм на основе биологически активных стандартизированных субстанций про- 
дуктов пчеловодства, которые имеют специфические химические и фармакологические свой-
ства для новых отечественных, природных, высокоэффективных лекарственных средств 
для профилактики и лечения язвенных заболеваний гастродуоденальной зоны человека. 
Проанализированы фармацевтический рынок лекарственных препаратов противоязвенной 
активности различных лекарственных форм и выяснено, что лекарственные формы, ко-
торые производятся в незначительном ассортименте экономически и социально целесоо-
бразны для дальнейшей разработки нового лекарственного препарата на основе продуктов 
пчеловодства. Сегодня наукой доказано, что перспективными в данном исследовании яв-
ляются капсулированные лекарственные формы. Данная лекарственная форма экономи-
чески выгодна и позволяет капсулировать различные лекарственные средства, начиная с 
веществ, которые находятся в твердом состоянии, до жидких и пастообразных ингреди-
ентов. Научными исследованиями последних лет подтверждено, что выбор рациональной 
лекарственной формы лекарственных веществ в комплексе со вспомогательными соеди-
нениями обеспечивает оптимальное фармакологическое действие разрабатываемых пре-
паратов, изготовление которых возможно как в промышленных, так и в аптечных условиях.
